CSB 2.009 Note
(mg) Prazepam;
CSB 2.009 Note
(4) Paragraph (hg) of s.
161.20 (2), Stats., is created to read:
CSB 2.009 Note
(hg) Midazolam;
CSB 2.009 Note
(5) Paragraph (mm) of s.
161.20 (2), Stats., is created to read:
CSB 2.009 Note
(mm) Quazepam;
CSB 2.009 Note
(6) Paragraph (km) of s.
161.18 (3), Stats., is created to read:
CSB 2.009 Note
(km) Tiletamine and Zolazepam or any salt thereof;
CSB 2.009 Note
(7) Paragraph (a) of s. 161.16 (3), Stats., is renumbered to read:
CSB 2.009 Note
(am) Alphaprodine;
CSB 2.009 Note
(8) Paragraph (a) of s.
161.16 (3), Stats., is created to read:
CSB 2.009 Note
(a) Alfentanil;
CSB 2.009 Note
(9) Paragraph (rg) of s.
161.14 (2), Stats., is created to read:
CSB 2.009 Note
(rg) MPPP 1-methyl-4-phenyl-4-propionoxypiperidine);
CSB 2.009 Note
(10) Paragraph (vg) of s.
161.14 (2), Stats., is created to read:
CSB 2.009 Note
(vg) (PEPAP) 1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine;
CSB 2.009 Note
(11) Paragraph (b) of s.
161.16 (10), Stats., is created to read:
CSB 2.009 Note
(b) Nabilone (another name for nabilone: (+)-trans-3- (1,1-dimethylheptyl)-6, 6a, 7, 8, 10, 10a-hexahydro-1- hydroxy-6, 6-dimethyl-9H-dibenzo [b,d] pyran-9-one).
CSB 2.009 Note
(12) Subsection
(2) of s.
161.14, Stats., is amended to read:
CSB 2.009 Note
(2) Opiates. Unless specifically excepted under federal regulations or unless listed in another schedule, any of the following opiates, or their isomers, esters, ethers, salts, salts of isomers, esters of ethers, if isomers, esters, ethers, salts or salts of isomers exist within the specified chemical designation (for purposes of par. (tg) only, the term isomer includes the optical and geometric isomers):
CSB 2.009 Note
(13) Paragraph (a) of s. 161.14 (2), Stats., is renumbered to read:
CSB 2.009 Note
(ag) Acetylmethadol;
CSB 2.009 Note
(14) Paragraph (a) of s.
161.14 (2), Stats., is created to read:
CSB 2.009 Note
(a) Acetyl-alpha-methylfentanyl (N-(1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide);
CSB 2.009 Note
(15) Paragraph (cg) of s.
161.14 (2), Stats., is created to read:
CSB 2.009 Note
(cg) Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide);
CSB 2.009 Note
(16) Paragraph (dg) of s.
161.14 (2), Stats., is created to read:
CSB 2.009 Note
(dg) Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl) -4-piperidinyl]-N-phenylpropanamide);
CSB 2.009 Note
(17) Paragraph (rj) of s.
161.14 (2), Stats., is created to read:
CSB 2.009 Note
(rj) 3-methylthiofentanyl (N-[3-methyl-1-(2-thienyl) ethyl-4-piperidinyl]-N-phenylpropanamide);
CSB 2.009 Note
(18) Paragraph (tg) of s.
161.14 (2), Stats., is created to read:
CSB 2.009 Note
(tg) Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1- (2-phenethyl)-4-piperidinyl]propanamide);
CSB 2.009 Note
(19) Paragraph (xm) of s.
161.14 (2), Stats., is created to read:
CSB 2.009 Note
(xm) Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]propanamide);
CSB 2.009 History
History:
Cr.
Register, February, 1988, No. 386, eff. 3-1-88.
CSB 2.009 Note
CSB 2.20 Addition of beta-hydroxy-3-methylfentanyl to schedule I. Paragraph (er) of s.
161.14 (2), Stats., is created to read:
CSB 2.009 Note
(er) Beta-hydroxy-3-methylfentanyl.
CSB 2.009 History
History:
Cr.
Register, July, 1989, No. 403, eff. 8-1-89.
CSB 2.009 Note
CSB 2.21 Additions, deletions, corrections, transfers, and amendments to drug schedules. (1) Subsection
(1) of s.
161.14, Stats., is amended to read:
CSB 2.009 Note
(1) Included substances. Unless specifically excepted by state or federal law or regulation or more specifically included in another schedule, the following controlled substances are listed in schedule I.
CSB 2.009 Note
(2) Paragraph (a) of s.
161.14 (2), Stats., is amended to read:
CSB 2.009 Note
(a) Acetyl-alpha-methylfentany (N-[1-(1-methyl-2-phenylethyl)-4-piperidinyl]-N-phenylacetamide);
CSB 2.009 Note
(3) Paragraph (er) of s.
161.14 (2), Stats., is amended to read:
CSB 2.009 Note
(er) Beta-hydroxy-3-methylfentanyl (N-[1-(2-hydroxy-2- phenylethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide);
CSB 2.009 Note
(4) Paragraph (rg) of s.
161.14 (2), Stats., is amended to read:
CSB 2.009 Note
(rg) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine);
CSB 2.009 Note
(5) Paragraph (qs) of s.
161.14 (2), Stats., is amended to read:
CSB 2.009 Note
(qs) 3-methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4-
piperidinyl]-N-phenylpropanamide);
CSB 2.009 Note
(6) Paragraph (tg) of s.
161.14 (2), Stats., is amended to read:
CSB 2.009 Note
(tg) Para-fluorofentanyl (N-[1-(2-phenylethyl)-4-piperidinyl]-N-(4-fluorophenyl)propanamide);
CSB 2.009 Note
(7) Paragraph (vg) of s.
161.14 (2), Stats., is amended to read:
CSB 2.009 Note
(vg) PEPAP (1-(2-phenylethyl)-4-phenyl-4-acetoxypiperidine);
CSB 2.009 Note
(8) Paragraph (xm) of s.
161.14 (2), Stats., is amended to read:
CSB 2.009 Note
(xm) Thiofentanyl (N-[1-(2-thienyl)ethyl-4-piperidinyl]-N-
phenylpropanamide);
CSB 2.009 Note
(9) Paragraph (cd) of s.
161.14 (2), Stats., is created to read:
CSB 2.009 Note
(cd) Alpha-methylfentanyl (N-[1-(1-methyl-2-phenylethyl)-4-piperidinyl]-N-phenylpropanamide);
CSB 2.009 Note
(10) Paragraph (e) of s.
161.14 (3), Stats., is amended to read:
CSB 2.009 Note
(e) Codeine-N-oxide;
CSB 2.009 Note
(11) Paragraph (j) of s.
161.14 (3), Stats., is amended to read:
CSB 2.009 Note
(j) Etorphine, except its hydrochloride salts;
CSB 2.009 Note
(12) Paragraph (s) of s.
161.14 (3), Stats., is amended to read:
CSB 2.009 Note
(s) Morphine-N-oxide;
CSB 2.009 Note
(13) Paragraph (a) of s.
161.14 (4), Stats., is amended to read:
CSB 2.009 Note
(a) 3,4-methylenedioxyamphetamine, commonly known as “MDA";
CSB 2.009 Note
(14) Paragraph (b) of s.
161.14 (4), Stats., is amended to read:
CSB 2.009 Note
(b) 5-methoxy-3,4-methylenedioxyamphetamine;
CSB 2.009 Note
(15) Paragraph (c) of s.
161.14 (4), Stats., is amended to read:
CSB 2.009 Note
(c) 3,4,5-trimethoxyamphetamine;
CSB 2.009 Note
(16) Paragraph (ag) of s.
161.14 (4), Stats., is created to read:
CSB 2.009 Note
(ag) 3,4-methylenedioxyethylamphetamine, commonly known as “MDE";
CSB 2.009 Note
(17) Paragraph (ar) of s.
161.14 (4), Stats., is created to read:
CSB 2.009 Note
(ar) N-hydroxy-3,4-methylenedioxyamphetamine;
CSB 2.009 Note
(18) Paragraph (u) of s.
161.14 (4), Stats., is amended to read:
CSB 2.009 Note
(u) 1-[1-(2-thienyl)cyclohexyl]piperidine, which is the thiophene analog of phencyclidine;
CSB 2.009 Note
(19) Paragraph (ud) of s.
161.14 (4), Stats., is created to read:
CSB 2.009 Note
(ud) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine, which is the thiophene pyrrolidine analog of phencyclidine;
CSB 2.009 Note
(20) Paragraph (ur) of s.
161.14 (4), Stats., is amended to read:
CSB 2.009 Note
(ur) 1-(1-phenylcyclohexyl)pyrrolidine, which is the pyrrolidine analog of phencyclidine;
CSB 2.009 Note
(21) Paragraph (d) of s.
161.14 (7), Stats., is created to read:
CSB 2.009 Note
(d) 4-methylaminorex, including its salts and salts of isomers;
CSB 2.009 Note
(22) Paragraph (e) of s.
161.14 (7), Stats., is created to read:
CSB 2.009 Note
(e) N,N-dimethylamphetamine, including its salts and salts of isomers.
CSB 2.009 Note
(23) Paragraph (L) of s.
161.14 (7), Stats., is created to read:
CSB 2.009 Note
(L) methcathinone, including its salts and salts of isomers.
CSB 2.009 Note
(24) Subdivision 4m of s.
161.16 (2) (a), Stats., is created to read:
CSB 2.009 Note
4m. Dihydrocodeine;
CSB 2.009 Note
(25) Paragraph (d) of s. 161.16 (3), Stats., is repealed.
CSB 2.009 Note
(26) Paragraph (am) of s.
161.16 (7), Stats., is created to read:
CSB 2.009 Note
(am) Glutethimide;
CSB 2.009 Note
(27) Subsection (9) of s. 161.16, Stats., is repealed.
